San Francisco-based Burrill & Company has completed a Series B round of financing in Bangalore-based Strand Life Sciences.
Burrill, a diversified global financial services firm focused on the life science industry, is the sole investor in this round, which included both a primary investment and a secondary buyout of the lead Series A investors. The fresh infusion will be used to expand the company’s presence in precision diagnostics and reach into global markets.
From the Venture Intelligence PE Deal database: Strand had raised $2.7 M from UTI Ventures in Nov-01, and $1.9 M from Sequoia in Sep-02.
Source: Press Release
Are you at APEX?
Where The Stars Foretell the Future of Indian PE/VC
Are you Showcasing at APEX?
Don't Miss Out on THE Most Effective Investor Networking Opportunity of the Year http://ventureintelligence.blogspot.in/2013/01/crucial-connect-to-venture-capital.html